Pendyala L - Search Results

1

Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.

Pendyala L, Kidani Y, Perez R, Wilkes J, Bernacki RJ, Creaven PJ. Pendyala L, et al. Cancer Lett. 1995 Nov 6;97(2):177-84. doi: 10.1016/0304-3835(95)03974-2. Cancer Lett. 1995. PMID: 7497460

2

DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II).

Pendyala L, Arakali AV, Sansone P, Cowens JW, Creaven PJ. Pendyala L, et al. Cancer Chemother Pharmacol. 1990;27(3):248-50. doi: 10.1007/BF00685722. Cancer Chemother Pharmacol. 1990. PMID: 2265462

3

Uptake and metabolism of iproplatin in murine L1210 cells.

Pendyala L, Walsh JR, Huq MM, Arakali AV, Cowens JW, Creaven PJ. Pendyala L, et al. Cancer Chemother Pharmacol. 1989;25(1):15-8. doi: 10.1007/BF00694332. Cancer Chemother Pharmacol. 1989. PMID: 2590997

4

Intracellular glutathione and cytotoxicity of platinum complexes.

Pendyala L, Creaven PJ, Perez R, Zdanowicz JR, Raghavan D. Pendyala L, et al. Cancer Chemother Pharmacol. 1995;36(4):271-8. doi: 10.1007/BF00689042. Cancer Chemother Pharmacol. 1995. PMID: 7628045

5

In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin.

Pendyala L, Creaven PJ. Pendyala L, et al. Cancer Res. 1993 Dec 15;53(24):5970-6. Cancer Res. 1993. PMID: 8261411

6

Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells.

el-akawi Z, Abu-hadid M, Perez R, Glavy J, Zdanowicz J, Creaven PJ, Pendyala L. el-akawi Z, et al. Among authors: pendyala l. Cancer Lett. 1996 Jul 19;105(1):5-14. doi: 10.1016/0304-3835(96)04245-0. Cancer Lett. 1996. PMID: 8689632

7

Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line.

el-akawi Z, Zdanowicz J, Creaven PJ, Abu-hadid M, Perez R, Pendyala L. el-akawi Z, et al. Among authors: pendyala l. Oncol Res. 1996;8(10-11):415-23. Oncol Res. 1996. PMID: 9114434

8

Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line.

Pendyala L, Perez R, Weinstein A, Zdanowicz J, Creaven PJ. Pendyala L, et al. Cancer Chemother Pharmacol. 1997;40(1):38-44. doi: 10.1007/s002800050622. Cancer Chemother Pharmacol. 1997. PMID: 9137527

9

Relationship between heat shock protein 60 (HSP60) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell lines.

Abu-Hadid M, Wilkes JD, Elakawi Z, Pendyala L, Perez RP. Abu-Hadid M, et al. Among authors: pendyala l. Cancer Lett. 1997 Oct 28;119(1):63-70. doi: 10.1016/s0304-3835(97)00255-3. Cancer Lett. 1997. PMID: 18372523

10

Studies on the human metabolism of iproplatin.

Pendyala L, Krishnan BS, Walsh JR, Arakali AV, Cowens JW, Creaven PJ. Pendyala L, et al. Cancer Chemother Pharmacol. 1989;25(1):10-4. doi: 10.1007/BF00694331. Cancer Chemother Pharmacol. 1989. PMID: 2590996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page